BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29285385)

  • 1. MHC class II associated stomach cancer mutations correlate with lack of subsequent tumor development.
    Yavorski JM; Blanck G
    Mol Clin Oncol; 2017 Dec; 7(6):1119-1121. PubMed ID: 29285385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Major histocompatibility complex class II transactivator (CIITA) hammer- head ribozyme transfer inhibits major histocompatibility complex class II (MHC-II) expression in Jukart cells].
    Guo R; Zou P; Song YP; Ma J; Lu HZ; Cao YL; Tong YJ
    Zhonghua Er Ke Za Zhi; 2003 Dec; 41(12):925-8. PubMed ID: 14723817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct genetic correction as a new method for diagnosis and molecular characterization of MHC class II deficiency.
    Matheux F; Ikinciogullari A; Zapata DA; Barras E; Zufferey M; Dogu F; Regueiro JR; Reith W; Villard J
    Mol Ther; 2002 Dec; 6(6):824-9. PubMed ID: 12498778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
    Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
    J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transcription factor RFX protects MHC class II genes against epigenetic silencing by DNA methylation.
    Seguín-Estévez Q; De Palma R; Krawczyk M; Leimgruber E; Villard J; Picard C; Tagliamacco A; Abbate G; Gorski J; Nocera A; Reith W
    J Immunol; 2009 Aug; 183(4):2545-53. PubMed ID: 19620312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mutations in the RFXANK gene: RFX complex containing in-vitro-generated RFXANK mutant binds the promoter without transactivating MHC II.
    Wiszniewski W; Fondaneche MC; Louise-Plence P; Prochnicka-Chalufour A; Selz F; Picard C; Le Deist F; Eliaou JF; Fischer A; Lisowska-Grospierre B
    Immunogenetics; 2003 Feb; 54(11):747-55. PubMed ID: 12618906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons from the bare lymphocyte syndrome: molecular mechanisms regulating MHC class II expression.
    Waldburger JM; Masternak K; Muhlethaler-Mottet A; Villard J; Peretti M; Landmann S; Reith W
    Immunol Rev; 2000 Dec; 178():148-65. PubMed ID: 11213800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor inhibition augments the expression of MHC class I and II genes.
    Pollack BP; Sapkota B; Cartee TV
    Clin Cancer Res; 2011 Jul; 17(13):4400-13. PubMed ID: 21586626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the RFX complex and the RFX5(L66A) mutant: implications for the regulation of MHC class II gene expression.
    Garvie CW; Stagno JR; Reid S; Singh A; Harrington E; Boss JM
    Biochemistry; 2007 Feb; 46(6):1597-611. PubMed ID: 17279624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The bare lymphocyte syndrome and the regulation of MHC expression.
    Reith W; Mach B
    Annu Rev Immunol; 2001; 19():331-73. PubMed ID: 11244040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NLRC5 exclusively transactivates MHC class I and related genes through a distinctive SXY module.
    Ludigs K; Seguín-Estévez Q; Lemeille S; Ferrero I; Rota G; Chelbi S; Mattmann C; MacDonald HR; Reith W; Guarda G
    PLoS Genet; 2015 Mar; 11(3):e1005088. PubMed ID: 25811463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-gamma inducibility of class II transactivator is specifically lacking in human tumour lines: relevance to retinoblastoma protein rescue of IFN-gamma inducibility of the HLA class II genes.
    Lu Y; Tschickardt ME; Schmidt BJ; Blanck G
    Immunol Cell Biol; 1997 Aug; 75(4):325-32. PubMed ID: 9315472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of MHCII genes by PRMT6, via an AT-hook motif of RFX5.
    Stavride P; Arampatzi P; Papamatheakis J
    Mol Immunol; 2013 Dec; 56(4):390-8. PubMed ID: 23911394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oct-1 DNA binding activity unresponsive to retinoblastoma protein expression prevents MHC class II induction in a non-small cell lung carcinoma cell line.
    Osborne AR; Zhang H; Blanck G
    Mol Immunol; 2006 Feb; 43(6):710-6. PubMed ID: 16360016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients.
    Masternak K; Barras E; Zufferey M; Conrad B; Corthals G; Aebersold R; Sanchez JC; Hochstrasser DF; Mach B; Reith W
    Nat Genet; 1998 Nov; 20(3):273-7. PubMed ID: 9806546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells.
    Satoh A; Toyota M; Ikeda H; Morimoto Y; Akino K; Mita H; Suzuki H; Sasaki Y; Kanaseki T; Takamura Y; Soejima H; Urano T; Yanagihara K; Endo T; Hinoda Y; Fujita M; Hosokawa M; Sato N; Tokino T; Imai K
    Oncogene; 2004 Nov; 23(55):8876-86. PubMed ID: 15467734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the expression of MHC class I and II by class II transactivator (CIITA) in hematopoietic cells.
    Liu A; Takahashi M; Toba K; Zheng Z; Hashimoto S; Nikkuni K; Furukawa T; Koike T; Aizawa Y
    Hematol Oncol; 1999 Dec; 17(4):149-60. PubMed ID: 10725870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assembly of the RFX complex on the MHCII promoter: role of RFXAP and RFXB in relieving autoinhibition of RFX5.
    Garvie CW; Boss JM
    Biochim Biophys Acta; 2008 Dec; 1779(12):797-804. PubMed ID: 18723135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H2-M, a facilitator of MHC class II peptide loading, and its negative modulator H2-O are differentially expressed in response to proinflammatory cytokines.
    Walter W; Scheuer C; Lingnau K; Reichert TE; Schmitt E; Loos M; Maeurer MJ
    Immunogenetics; 2000 Aug; 51(10):794-804. PubMed ID: 10970094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of nonhematopoietic MHC class II expression protects mice from experimental autoimmune myocarditis.
    Thelemann C; Haller S; Blyszczuk P; Kania G; Rosa M; Eriksson U; Rotman S; Reith W; Acha-Orbea H
    Eur J Immunol; 2016 Mar; 46(3):656-64. PubMed ID: 26621778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.